Loading
Latest filing published 06 Feb 2026 for Eikon Therapeutics, Inc., €2.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Josh Wolfe, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Shapeways Holdings, Inc. and Eikon Therapeutics, Inc. Over a trading history stretching from 29 September 2021 to 4 February 2026, the count stands at 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €2.1M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 6 February 2026, reports an open-market purchase of €2.1M in Eikon Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations